Brentuximab a novel antibody therapy: Real‐World Use Confirms Efficacy and Tolerability for CD30 positive cutaneous lymphoma

Published 2019 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Brentuximab a novel antibody therapy: Real‐World Use Confirms Efficacy and Tolerability for CD30 positive cutaneous lymphoma
Authors
Keywords
-
Journal
BRITISH JOURNAL OF DERMATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-09-17
DOI
10.1111/bjd.18535

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.